Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

A railway worker demonstrates how to use a fire blanket during a fire safety training in Liangjiang New Area, Southwest China ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.